We are live on ! Find out more
MESO

Mesoblast

29 hedge funds and large institutions have $16M invested in Mesoblast in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 1

800% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 1

45% more funds holding

Funds holding: 2029 (+9)

2% more capital invested

Capital invested by funds: $15.8M → $16M (+$273K)

0.01% more ownership

Funds ownership: 0.29%0.29% (+0.01%)

Holders
29
Holders Change
+9
Holders Change %
+45%
% of All Funds
0.66%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
9
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
IA
26
IFP Advisors
Florida
$6K
PA
27
Parallel Advisors
California
$2K +$1.61K +134 New
MOS
28
MGO One Seven
Ohio
$1K
Goldman Sachs
29
Goldman Sachs
New York
-$835K -71,500 Closed

MESO Hedge Fund Activity: Q1 2018 in Review

29 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q1 2018, worth a combined $16M — up 1.7% from $15.8M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new MESO positions and 1 closed out — a net gain of 9 holders — while 9 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $268K. The largest seller was Goldman Sachs, exiting entirely with an estimated $835K sold.

  • 29 institutional investors held Mesoblast (MESO) as of Q1 2018, up from 20 in Q4 2017.
  • Funds reported $16M of Mesoblast stock for Q1 2018, up 1.7% quarter-over-quarter.
  • 10 funds opened new Mesoblast positions in Q1 2018 and 1 closed out, a net change of +9 holders.
  • The largest Mesoblast buyer in Q1 2018 was Renaissance Technologies, an estimated $268K added.
  • The largest Mesoblast seller in Q1 2018 was Goldman Sachs, an estimated $835K sold.

Based on aggregated 13F filings for Q1 2018.